- Report
- April 2025
- 205 Pages
Global
From €4404EUR$4,995USD£3,868GBP
- Report
- February 2025
- 140 Pages
Global
From €3634EUR$4,123USD£3,192GBP
€4276EUR$4,850USD£3,756GBP
- Report
- August 2025
- 200 Pages
United States
From €2195EUR$2,490USD£1,928GBP
- Report
- October 2025
- 183 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 183 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 181 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 184 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 197 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 197 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 190 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- July 2025
Global
From €4320EUR$4,900USD£3,794GBP
- Report
- April 2025
- 200 Pages
Global
From €5607EUR$6,360USD£4,925GBP
€7009EUR$7,950USD£6,156GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1411EUR$1,600USD£1,239GBP
€1763EUR$2,000USD£1,549GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1058EUR$1,200USD£929GBP
€1322EUR$1,500USD£1,162GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2116EUR$2,400USD£1,858GBP
€2645EUR$3,000USD£2,323GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1411EUR$1,600USD£1,239GBP
€1763EUR$2,000USD£1,549GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €882EUR$1,000USD£774GBP
€1102EUR$1,250USD£968GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1058EUR$1,200USD£929GBP
€1322EUR$1,500USD£1,162GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €882EUR$1,000USD£774GBP
€1102EUR$1,250USD£968GBP
- Report
- December 2025
- 196 Pages
Global
From €5157EUR$5,850USD£4,530GBP

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more